Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being
Ernie Anand,1 Lovisa Berggren,2 John Landry,3 Ágoston Tóth,4 Holland C Detke5 1Neuroscience Medical Affairs, Eli Lilly & Company Ltd, Windlesham, UK; 2Global Statistical Sciences, Lilly Deutschland GmbH, Bad Homburg, Germany; 3Global Statistical Sciences, E...
Saved in:
Main Authors: | Anand E, Berggren L, Landry J, Tóth Á, Detke HC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-outcomes-with-olanzapine-long-acting-injection-impact-of-the--peer-reviewed-fulltext-article-NDT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabrication and Ex-vivo Evaluation of Olanzapine Nanoparticles Based Dissolved Microneedle for Transdermal Delivery
by: Abulfadhel jaber neamah AL-shaibani, et al.
Published: (2025-06-01) -
Effect of olanzapine on laying performance of Americal king pigeons and approach to the mechanisms
by: ZHAO Wen-jing, et al.
Published: (2011-01-01) -
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
by: Montemagni C, et al.
Published: (2016-04-01) -
Negative Impact of Olanzapine on ICU Delirium Resolution: An Emulated Clinical Trial
by: Ajna Hamidovic, et al.
Published: (2025-07-01) -
Tunable Intranasal Polymersome Nanocarriers Triggered Olanzapine Brain Delivery and Improved In Vivo Antipsychotic Activity
by: Ahmed A. Katamesh, et al.
Published: (2025-06-01)